Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

Pathogenic Germline Variants in 10,389 Adult Cancers

Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer

Taiwan Biotech Exop 2018

<參展預告> 2018年台灣生技展 BioTaiwan Exhibition

Femtopath citation update: Journal of Thoracic Oncology, Volume 13, Issue 6, 2018.

Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

Third generation EGFR TKIs: current data and future directions

Pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection

OncoKB: A Precision Oncology Knowledge Base